ZARA · ACTIVE
00:00:00 UTC
Automated Science
OpenScientist
The frontier of science, automated.
01Autonomous hypotheses
02Proprietary tool access
03Self-authored briefs
04Compounding research
The best automated AI scientist. Discovering at the frontier.
Real hypotheses. Real experiments. Real research.
Introducing Zara
Research that moves on its own.
Zara plans, collaborates, runs scientific tools, evaluates results, and improves through reinforcement learning.
Planning the research
Objective
Identify an antibody candidate with stronger target binding and acceptable developability.
- 1Review target constraints
- 2Generate candidate sequences
- 3Evaluate binding and stability
Searching recent antibody design literature
PubMed
bioRxiv
Protein Data Bank
Affinity maturation of therapeutic antibodies
Nature Biotech · retained
Developability prediction from sequence
bioRxiv · retained
Running structural docking
Docking Agent
Connecting to structural docking server
Connection established
12 candidate poses submitted
Sequence Agent
produced 24 candidates
Evaluation Agent
requested developability checks
Shared workspace updated
24 candidates evaluated · 5 advanced
CandidateBindingStabilityDevelop.
ZR-17
Selected
ZR-09
Advanced
ZR-22
Advanced
ZR-31
Rejected
Candidate ZR-17 selected
Reinforcement learning environment
Antibody Candidate ZR-17
Selected after literature review, sequence generation, structural docking, and multi-objective evaluation.
Candidate sequence
Docking results
Evaluation summary
References
Research brief
Policy confidence
Research brief complete
Confidence high
Rewarding stronger scientific decisions
Decision
Action
Reward
- Valid hypothesis+1.2
- Tool selection+0.8
- Failed docking path−0.4
- Improved candidate ranking+1.6
Evidence Agent
Stronger binding affinity confirmed[1]
Developability within accepted range[2]
Low aggregation risk predicted[3]
references.bib created
Capabilities
How Zara works
01
Tool-connected
Servers & lab APIs
02
Hypothesis-driven
Parallel research threads
03
End-to-end
Idea to written brief
04
Compounding
Each result sharpens the next
Case study
Self-authored antibody generative discovery.
Zara scoped, built, and evaluated a de novo antibody generative model. Then she wrote the brief herself.
De novo sequencesAutonomous pipelineZero human drafting
Autonomous Antibody Generative Discovery
Get access
Join the waitlist for Zara
Be first in line.
You're in
We'll reach out as we open access.